The Scientist

» biosimilars

Most Recent

image: FDA OKs First Biosimilar

FDA OKs First Biosimilar

By | March 6, 2015

The US Food and Drug Administration approves Sandoz’s Zarxio, a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.

2 Comments

image: Pfizer to Acquire Hospira

Pfizer to Acquire Hospira

By | February 5, 2015

The pharmaceutical giant is purchasing the injectable drugmaker for about $15 billion.

0 Comments

image: Obamacare Will Affect Research

Obamacare Will Affect Research

By | June 29, 2012

The Supreme Court's decision to uphold President Barack Obama's health care reform law contains key provisions that will impact US science funding in the years to come.

28 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

Advertisement

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. How Fats Influence the Microbiome
  3. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  4. Influential Cancer Biologist Dies
Advertisement
Advertisement
Life Technologies